Editing the Genome to Cure Genetic Disease

Casebia combines CRISPR/Cas9 expertise and technology from CRISPR Therapeutics with access to deep disease-state knowledge and protein engineering capabilities from Bayer. Our aim: to transform the lives of patients and families affected by genetic disease.

Social Media

Our CSO Andy Scharenberg spoke on several panels at the ‘In Vivo #GeneTherapy and #GeneEditing Summit’. Thanks to the other panelists, @ChardanCM for presenting the Summit, and the Orphan Disease Center at UPenn (@MDBRide4Rare) for organizing a great event.

We were proud to participate with @Bayer for the recent SF #STEM Career Day. @SFUnified high school students toured the #MissionBay CoLaborator space, our labs & met with members of our team. This program is sponsored by Bayer Healthcare & @Salesforce and organized by @SEP_UCSF.

See us on Twitter